Skip to main content

Table 3 Univariate analysis of prognostic factors related to overall survival (OS) and progression-free survival (PFS)

From: Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis

Factor

5-year PFS (%)

p

5-year OS (%)

p

Single or double

 Single-agent

40.9

0.367

62.7

0.161

 Double-agent

52.5

 

78.2

 

Stage

 I

65.2

0.006

91.1

0.005

 II

42.7

 

67.1

 

 III

32.8

 

47.6

 

 Sex

 

0.47

 

0.346

 Male

42.2

 

66.7

 

 Female

58.2

 

75.6

 

Radiotherapy

 dose (Gy)

    

  > 60

43.8

0.287

65.8

0.735

 50–60

50.6

 

70.8

 

Age (years)

  ≥ 65

21.8

0.115

61.3

0.698

  < 65

55.7

 

74.9

 
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us